| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443856 | European Journal of Cancer | 2014 | 7 Pages |
Abstract
Type I PPB patients' outcome was satisfactory. Complete resection at diagnosis seems important but rarely feasible for type II/III tumours, who benefited from doxorubicin-containing CT regimens. These results will inform the EXPeRT group's PPB treatment guidelines.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Gianni Bisogno, Bernadette Brennan, Daniel Orbach, Teresa Stachowicz-Stencel, Giovanni Cecchetto, Paolo Indolfi, Ewa Bien, Andrea Ferrari, Florence Dommange-Romero,